Myocarditis (peds): Difference between revisions

(4 intermediate revisions by the same user not shown)
Line 2: Line 2:
==Background==
==Background==
*Rare but potentially fatal
*Rare but potentially fatal
*Most common cause of heart failure in previously healthy children, also one of the etiologies for unexpected sudden cardiac death  
*Most common cause of heart failure in previously healthy children, also one of the etiologies for unexpected sudden cardiac death in infants
*Inflammation of myocardium
*Inflammation of myocardium
**Can lead to dilated [[cardiomyopathy]]
**Can lead to dilated [[cardiomyopathy]]
Line 34: Line 34:


==Evaluation==
==Evaluation==
*Blood work
**Elevated [[troponin]]<ref>Eisenberg MA1, Green-Hopkins I, Alexander ME, Chiang VW. Cardiac troponin T as a screening test for myocarditis in children</ref>
**Elevated BNP<ref>Koulouri S, Acherman RJ, Wong PC, et al. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004; 25:341</ref>
**Markers of inflammation such as ESR and CRP may be elevated, but are nonspecific
**Elevated [[LFTs]]
**Blood gas to evaluate for systemic perfusion
*[[ECG]]
*[[ECG]]
**[[Sinus tachycardia]] is most common abnormality
**[[Sinus tachycardia]] is most common abnormality
**Other abnormalities includes<ref>Freedman SB1, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics. 2007 Dec;120(6):1278-85.</ref>
**Other abnormalities includes<ref>Freedman SB1, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics. 2007 Dec;120(6):1278-85.</ref>
**Large voltage
***Low voltage
**Axis deviation
***Axis deviation
**ST or [[T wave changes]]
***ST or [[T wave changes]]
**[[AV blocks]]
***[[AV blocks]] or conduction delays
**[[myocardial ischemia|Ischemic]] patterns
***[[myocardial ischemia|Ischemic]] patterns
***SVT or ventricular arrhythmias<ref>Batra AS, Epstein D, Silka MJ. The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol 2003; 24:495</ref>
*[[CXR]]
*[[CXR]]
**Not sensitive, but often abnormal<ref>Durani Y1, Egan M, Baffa J, Selbst SM, Nager AL. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med. 2009 Oct;27(8):942-7.</ref>
**Not sensitive, but often abnormal<ref>Durani Y1, Egan M, Baffa J, Selbst SM, Nager AL. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med. 2009 Oct;27(8):942-7.</ref>
Line 49: Line 56:
*[[Echocardiography]]
*[[Echocardiography]]
**Unnecessary if both CXR and ECG are normal, unless you have high clinical suspicion
**Unnecessary if both CXR and ECG are normal, unless you have high clinical suspicion
*Elevated [[LFTs]], [[troponin]] in many cases<ref>Eisenberg MA1, Green-Hopkins I, Alexander ME, Chiang VW. Cardiac troponin T as a screening test for myocarditis in children</ref>


==Management==
==Management==
*Management tailored to severity of disease
*Management tailored to severity of disease
*Maintain euvolemia, [[diuretics]] as needed
*Maintain euvolemia, consider [[furosemide]] as needed
*If cardiac function significantly depressed, consider [[dopamine]] or [[dobutamine]]
*If cardiac function significantly depressed, consider [[epinephrine]] or [[dopamine]]
*Consider afterload reduction with [[nitroprusside]] if normotensive  
*Consider afterload reduction with [[nitroprusside]] if normotensive  
*Treat [[arrhythmias]]  
*Treat [[arrhythmias]]  
**Unstable - cardioversion at 0.5-1 J/kg (max 2J/kg)
**Stable - consider lidocaine or amiodarone
**Avoid digoxin due to risk of precipitating more significant dysrhythmias in irritable myocardium
**Avoid digoxin due to risk of precipitating more significant dysrhythmias in irritable myocardium
*Admit to Pediatric ICU, preferably with ECMO capabilities


==Disposition==
==Disposition==

Revision as of 04:22, 16 May 2020

This page is for pediatric patients. For adult patients, see: myocarditis

Background

  • Rare but potentially fatal
  • Most common cause of heart failure in previously healthy children, also one of the etiologies for unexpected sudden cardiac death in infants
  • Inflammation of myocardium
  • Typically viral but often no pathogen identified. Other causes include bacterial, toxins, and autoimmune causes

Clinical Features

Differential Diagnosis

Pediatric Shortness of Breath

Pulmonary/airway

Cardiac

Other diseases with abnormal respiration

Evaluation

Management

  • Management tailored to severity of disease
  • Maintain euvolemia, consider furosemide as needed
  • If cardiac function significantly depressed, consider epinephrine or dopamine
  • Consider afterload reduction with nitroprusside if normotensive
  • Treat arrhythmias
    • Unstable - cardioversion at 0.5-1 J/kg (max 2J/kg)
    • Stable - consider lidocaine or amiodarone
    • Avoid digoxin due to risk of precipitating more significant dysrhythmias in irritable myocardium
  • Admit to Pediatric ICU, preferably with ECMO capabilities

Disposition

  • Admit, often to ICU

See Also

External Links

References

  1. Freedman SB1, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics. 2007 Dec;120(6):1278-85.
  2. Dancea AB. Myocarditis in infants and children: A review for the paediatrician. Paediatr Child Health. 2001;6(8):543–545. doi:10.1093/pch/6.8.543
  3. Durani Y1, Egan M, Baffa J, Selbst SM, Nager AL. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med. 2009 Oct;27(8):942-7.
  4. Durani Y1, Egan M, Baffa J, Selbst SM, Nager AL. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med. 2009 Oct;27(8):942-7.
  5. Freedman SB1, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics. 2007 Dec;120(6):1278-85.
  6. Shu-Ling C1, Bautista D, Kit CC, Su-Yin AA. Diagnostic evaluation of pediatric myocarditis in the emergency department: a 10-year case series in the Asian population. Pediatr Emerg Care. 2013 Mar;29(3):346-51.
  7. Eisenberg MA1, Green-Hopkins I, Alexander ME, Chiang VW. Cardiac troponin T as a screening test for myocarditis in children
  8. Koulouri S, Acherman RJ, Wong PC, et al. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004; 25:341
  9. Freedman SB1, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics. 2007 Dec;120(6):1278-85.
  10. Batra AS, Epstein D, Silka MJ. The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol 2003; 24:495
  11. Durani Y1, Egan M, Baffa J, Selbst SM, Nager AL. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med. 2009 Oct;27(8):942-7.